Abstract:Yijuan Feng, 1, &ast Yan Wang, 1, &ast Li Li, 1, &ast Yan Yang, 1 Xiaoqiu Tan, 1– 3 Tangting Chen 1, 2 1 Key Laboratory of Medical Electrophysiology of the Ministry of Education, Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan, People's Republic of China; 2 Department of Cardiology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China; 3 Department of Physiology, School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Tangting Chen; Xiaoqiu Tan, Key Laboratory of Medical Electrophysiology of the Ministry of Education, Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan, People's Republic of China, Email ; Recanalization therapy can significantly improve the prognosis of patients with acute myocardial infarction (AMI). However, infarction or reperfusion-induced cardiomyocyte death, immune cell infiltration, fibroblast proliferation, and scarring formation lead to cardiac remodeling and gradually progress to heart failure or arrhythmia, resulting in a high mortality rate. Due to the inability of cardiomyocytes to regenerate, the healing of infarcted myocardium mainly relies on the formation of scars. Cardiac fibroblasts, as the main effector cells involved in repair and scar formation, play a crucial role in maintaining the structural integrity of the heart after MI. Recent studies have revealed that exosome-mediated intercellular communication plays a huge role in myocardial repair and signaling transduction after myocardial infarction (MI). Exosomes can regulate the biological behavior of fibroblasts by activating or inhibiting the intracellular signaling pathways through their contents, which are derived from cardiomyocytes, immune cells, endothelial cells, mesenchymal cells, and others. Understanding the interactions between fibroblasts and other cell types during cardiac remodeling will be the key to breakthrough therapies. This review examines the role of exosomes from different sources in the repair process after MI injury, especially the impacts on fibroblasts during myocardial remodeling, and explores the use of exosomes in the treatment of myocardial remodeling after MI. Keywords: exosomes, myocardial infarction, myocardial fibrosis, cardiac fibroblasts Myocardial infarction (MI) is the most serious manifestation of coronary artery disease and a major cause of related deaths. 1 The main clinical treatment for MI aims to unblock the coronary artery, restore blood flow, and minimize post-infarction myocardial remodeling. 2 Adult myocardial cells cannot regenerate after necrosis, so the maintenance of normal cardiac structure after MI mainly relies on the proliferation of fibroblasts. 3 However, cardiac fibrosis and remodeling caused by continuous fibroblast activation 4 still requires the further search for new therapeutic strategies. Studies on extracellular vesicles have exponentially increased in the past decade, from basic researches to clinical translational applications. Due to the endogenous, biocompatible and multifunctional properties, the extracellular vesicles may become a novel treatment for various cardiac diseases in the future. 5,6 Exosomes being paracrine is a key pathway for intercellular information exchange, transporting critical proteins 7 and genetic material (such as miRNA, 8 mRNA, 9 and DNA 10 ), mediating the transfer of various biomolecules between cells, which is an important component of various physiological and pathological processes. 11 Recent studies have shown that various types of cells, including myocardial cells, 12,13 endothelial cells (ECs), 14 immune cells, 15 and stem cells, 16 can secrete extracellular vesicles to participate in the process of myocardial remodeling. Certain extracellular vesicles exhibit significant advantages in myocardial remodeling after heart attack, while others aggravate the progression of myocardial remodeling. Although there are literature reviews on the effects of exosomes on cardiovascular diseases, as well as how the contents of exosomes (microRNA (miRNA), non-coding RNAs (ncRNA), long non-coding RNAs (lncRNA) et al) affect cardiac fibrosis or myocardial remodeling processes after MI, 17–19 there is currently no literature that specifically explains how exosomes and the -Abstract Truncated-

Exosomes Induce Crosstalk Between Multiple Types of Cells and Cardiac Fibroblasts: Therapeutic Potential for Remodeling After Myocardial Infarction